Generic drugmaker Dr. Reddy’s Laboratories’ analysis and growth centre in Hyderabad has accomplished a United States Meals and Drug Administration (USFDA) inspection.
“The USFDA at this time accomplished a routine good manufacturing apply (GMP) inspection at our R&D centre (Built-in Product Growth Organisation or IPDO) in Bachupally, Hyderabad. The inspection, carried out from September 16-20, closed with zero observations, the corporate mentioned in a submitting on Friday.
Revealed – September 20, 2024 10:16 pm IST
